The global intrathecal pump market is anticipated to grow at a considerable CAGR of 6.1% during the forecast period. The rising number of chronic disorders such as chronic pancreatitis, back pain, cancer, and injury among others is boosting the global intrathecal pump market during the forecast period as these intrathecal pumps are used for providing medication directly to the affected part for proper relief majorly to the spinal cord. According to the Miami Project to Cure Paralysis and National SCI statistical center (NSCISC) data published in 2018, around 17,810 new spinal cord injuries occur each year in the US, out of which males account for about 78% of new SCI (spinal cord injury) cases.
Browse the full report description of “Intrathecal Pumps Market Size, Share & Trends Analysis Report by Type (Baclofen, Bupivacaine, Clonidine, Morphine, Ziconotide, and Others), by Application (Spasticity, and Pain), and by End-User (Hospitals & Clinics, and Ambulatory Surgery Centers) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/intrathecal-pumps-market
• Around, 294,000 people with SCI (spinal cord injury) live in the US with a range of 250,000 to 368,000 persons, with an average age at the time of injury being 43 years old. The majority of these cases are due to causes such as road traffic accidents, falls, violence, and others. Premature deaths are two to five times more common in people with SCI than in people without a spinal cord injury.
• Spinal cord injury (SCI) resulting in paralysis has devastating physical, mental, social, and vocational consequences for the injured on his life.
There are many potential complications related to spinal cord injury that may require proper treatments and medication. These complications include urinary tract infections, inability to control bowel movements, chronic pain, pressure sores, infection in the lungs, depression, deep vein thrombosis, osteoporosis, and respiratory complications. Hence, to avoid these complications the patients need proper and effective medication such as in form of intrathecal drug delivery systems which directly provides medicine to the affected areas and helps in recovering fast. Furthermore, according to the centers for diseases control and prevention (CDC), data in 2019 around 39.0% of adults had back pain, 36.5% had lower limb pain, and 30.7% had upper limb pain in the past 3 months in the US. Women (40.6%) were more likely to experience back pain than men (37.2%). These strong factors boost the demand for these pain pumps in the market.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Type
o By Application
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- including Flowonix Medical, Inc., Medical Device Business Services, Inc. (Johnson & Johnson), Teleflex, Inc., Tricumed Medizintechnik GmbH, Zimmer Biomet Holdings, Inc., and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Intrathecal Pump Market Report Segment
By Type
By Application
By End-User
Global Intrathecal Pump Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/intrathecal-pumps-market